Please login to the form below

Not currently logged in


This page shows the latest osteoporosis news and features for those working in and with pharma, biotech and healthcare.

bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video

bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video

Side effects from this treatment can cause complications such as organ damage, osteoporosis and problems with the heart, liver and endocrine system resulting in reduced life expectancy.

Latest news

More from news
Approximately 11 fully matching, plus 193 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    Japan’s health system is seeing a corresponding rise in the conditions common to an ageing population, such as cardiac disease, autoimmune diseases, diabetes, osteoporosis and osteoarthritis.

  • On our best behaviour On our best behaviour

    Poor adherence for example can completely undermine the value of medication – one study showed that poor adherence with osteoporosis medications results in around a 50% reduction in the potential benefits observed

  • The evolution of marketing – the Amgen way The evolution of marketing – the Amgen way

    There is tremendous opportunity – and a massive need – to bend the curve for serious illnesses, such as cancer, cardiovascular disease and osteoporosis, which affect tens of millions of people worldwide.

  • Case study: frACTure Case study: frACTure

    The campaign featured on- and off-line communications and activities that educated employees about osteoporosis and fractures. ... It showed how committed the company is to raising awareness of osteoporosis and fragility fractures.

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • #DemandDiversity: The science behind diversity #DemandDiversity: The science behind diversity

    Caucasian and Asian women are more likely to develop osteoporosis than women of other ethnic backgrounds, andare more likely to develop Type 2 diabetes than the rest of the population.

  • Osteoblast Hackathon

    Bringing together the disease community to hack ideas using design thinking as our foundation. 44 (0) 7817 410079. Address:. St. John’s House. 54 St. John’s Square. London. EC1V 4JL.

  • Cuttsy+Cuttsy launch their latest patient e-book

    Osteoporosis is a chronic condition that affects up to one in three people aged 50 and over. ... If you or someone you know has osteoporosis, this book might help take some of the unknown away.

  • How can pharma engage with key stakeholders on NHS service transformation?

    NHS RightCare provides examples of this with its long-term condition scenarios, such as ‘Susan’s Story: Osteoporosis’, where costs are shown to be reduced by a factor of 10 if

  • Maximising ROI from mature brands

    News that Eli Lilly and Co has forecast a drop in 2014 profits and reduced its sales outlook because of generic competition to its Cymbalta antidepressant and Evista drug for osteoporosis,

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...